{"status":"success","data":{"title":"Kawasaki Disease","slug":"kawasaki","tags":null,"collection":["Pediatrics"],"content":"<h1 id=\"kawasaki-disease\">Kawasaki Disease</h1>\n<p><strong>Definition:</strong> Acute, self-limited vasculitis of unknown etiology that occursmostly in infants and young children </p>\n<p><strong>Classic clinical criteria</strong></p>\n<ol>\n<li><strong>Fever for ≥ 5 days</strong>, AND</li>\n<li>At least <strong>4</strong> of the 5 following:</li>\n</ol>\n<ul>\n<li>Bilateral bulbar nonexudative conjunctivitis</li>\n<li>Cervical lymphadenopathy (&gt; 1.5 cm diameter), usually unilateral</li>\n<li>Changes in lips and oral cavity<ul>\n<li>Erythema</li>\n<li>Lip cracking</li>\n<li>Strawberry tongue</li>\n<li>Diffuse injection of oral/pharyngeal mucosae</li>\n</ul>\n</li>\n<li>Changes in extremities<ul>\n<li>Acute: Erythema of palms or soles; edema of hands or feet</li>\n<li>Subacute: Periungual peeling of fingers or toes in weeks #2-3&nbsp;</li>\n</ul>\n</li>\n<li>Polymorphous rash</li>\n</ul>\n<p><img src=\"https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/053e3455-6dbd-5668-9861-6fe521dad8be/640.png\" alt=\"\"></p>\n<h2 id=\"complications-and-differential-diagnosis\">Complications and differential diagnosis</h2>\n<p><strong>Complication:</strong> Coronary artery aneurysms/ ectasis --&gt; risk of MI,sudden death, ischemic heart disease (15-25% untreated, 5% if treated)</p>\n<p><strong>Differential Diagnosis</strong></p>\n<ul>\n<li>Viral infections (measles, adenovirus, enterovirus, EBV)</li>\n<li>Scarlet fever</li>\n<li>Staphylococcal scalded skin syndrome</li>\n<li>Toxic shock syndrome</li>\n<li>Bacterial cervical lymphadenitis</li>\n<li>Drug hypersensitivity reaction</li>\n<li>Stevens-Johnson syndrome</li>\n<li>Juvenile rheumatoid arthritis</li>\n<li>Rocky Mountain Spotted Fever</li>\n<li>Leptospirosis</li>\n<li>Mercury hypersensitivity reaction </li>\n</ul>\n<h2 id=\"aha-2004-guideline-evaluation-of-suspected-incomplete-kawasaki-disease\">AHA 2004 guideline: Evaluation of suspected incomplete Kawasaki Disease</h2>\n<p><img src=\"https://d2p53dh3qxfm0x.cloudfront.net/uploads/img/1jx/5/m/b55fbb14-0d75-5bf1-bb23-712f90bee994/640.png\" alt=\"\"></p>\n<p><strong>AHA consensus recommendations</strong></p>\n<ol>\n<li>Infants ≤ 6 months old on day ≥ 7 of fever without other explanation should undergo lab testing and, if evidence of systemic inflammation is found, an echocardiogram, even if they have no clinical criteria</li>\n<li>Check for classic findings</li>\n<li>Supplemental lab criteria<ul>\n<li>Albumin ≤3.0 g/dL</li>\n<li>Anemia for age</li>\n<li>Elevation of ALT</li>\n<li>Platelets after 7 d ≥450,000/mm3</li>\n<li>WBC ≥15,000/mm3,</li>\n<li>Urine ≥10 WBC/hpf</li>\n</ul>\n</li>\n<li>Can treat before performing echocardiogram.</li>\n<li>Echo is considered positive for purposes of this algorithm, if any of 3 conditions met: <ul>\n<li>z score of LAD or RCA ≥ 2.5</li>\n<li>Coronary arteries meet Japanese Ministry of Health criteria for aneurysms, or </li>\n<li>≥ 3 other suggestive features exist, including: perivascular brightness, lack of tapering, decreased LV function, mitral regurgitation, pericardial effusion, or z scores in LAD or RCA of 2–2.5</li>\n</ul>\n</li>\n<li>If echo is positive, treatment should be given to children within 10 d of fever onset and those &gt; day 10 with clinical and lab signs (CRP, ESR) of ongoing inflammation</li>\n<li>Typical peeling begins under nail bed of fingers and then toes</li>\n</ol>\n<h2 id=\"references\">References</h2>\n<ul>\n<li><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/?term=15505111\">Newburger JW et. al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.Circulation. 2004 Oct 26;110(17):2747-71.</a></li>\n</ul>\n"}}